2-keto-3-deoxyoctonate has been researched along with Infections, Chlamydia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cram, ED | 1 |
| Rockey, DD | 1 |
| Dolan, BP | 1 |
| Fadel, S | 1 |
| Eley, A | 1 |
2 other studies available for 2-keto-3-deoxyoctonate and Infections, Chlamydia
| Article | Year |
|---|---|
Chlamydia spp. development is differentially altered by treatment with the LpxC inhibitor LPC-011.
Topics: Amino Acid Sequence; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Proteins; Cell Line; Chla | 2017 |
Is lipopolysaccharide a factor in infectivity of Chlamydia trachomatis?
Topics: Cell Line, Tumor; Chlamydia Infections; Chlamydia trachomatis; Epithelial Cells; Humans; Immunohisto | 2008 |